Stereotaxis, Inc. to Present at the C.E. Unterberg, Towbin Emerging Growth Conference

ST. LOUIS, July 5 /PRNewswire-FirstCall/--Stereotaxis, Inc. , announced today that Bevil J. Hogg, Chief Executive Officer, and James M. Stolze, Chief Financial Officer, will present at the C.E. Unterberg, Towbin Emerging Growth Conference at the Mandarin Oriental Hotel in New York City, on Wednesday, July 11, 2007 at 2:00 p.m. Eastern Time.

Attendance at the conference is by invitation only. The audio presentation will be webcast live and remain available for 90 days at http://www.wsw.com/webcast/ceut6/stxs/.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.

CONTACT: Jim Stolze, Chief Financial Officer of Stereotaxis, Inc.,+1-314-678-6105; investors, Douglas Sherk and Jenifer Kirtland,+1-415-896-6820, or Jennifer Beugelmans, +1-646-201-5447, or media, SteveDiMattia, +1-646-201-5445, all of EVC Group, Inc., for Stereotaxis, Inc.

Web site: http://www.stereotaxis.com/